Cargando…

Advances in Tumour-Infiltrating Lymphocytes for Triple-Negative Breast Cancer Management

Triple negative breast cancer (TNBC) is a subtype of breast cancer which does not express or expresses a minimum amount of estrogen receptors (ER), progesterone receptors (PR) and human epidermal growth factor receptor 2 (HER2) protein. TNBCs include a heterogenic group of cancers that are aggressiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorenšek, Rok, Kresnik, Martin, Takač, Iztok, Rojko, Tomaž, Sobočan, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627091/ https://www.ncbi.nlm.nih.gov/pubmed/37936879 http://dx.doi.org/10.2147/BCTT.S399157

Ejemplares similares

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021)

Clinical features and their effect on outcomes of patients with triple negative breast cancer with or without lymph node involvement
por: Sobočan, Monika, et al.
Publicado: (2019)

Advances in Diagnostics and Management of Gestational Trophoblastic Disease
por: Lukinovic, Nusa, et al.
Publicado: (2022)

Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
por: Balkenhol, Maschenka CA., et al.
Publicado: (2021)

Low Selenium Levels in Amniotic Fluid Correlate with Small-For-Gestational Age Newborns
por: Ogrizek-Pelkič, Ksenija, et al.
Publicado: (2020)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
por: Skok, Kristijan, et al.
Publicado: (2021)

The Perspectives of Fertility Preservation in Women with Endometrial Cancer
por: Knez, Jure, et al.
Publicado: (2021)

Pre-treatment Risk Assessment of Women with Endometrial Cancer: Differences in Outcomes of Molecular and Clinical Classifications in The Slovenian Patient Cohort
por: Knez, Jure, et al.
Publicado: (2021)

The Communication between the PI3K/AKT/mTOR Pathway and Y-Box Binding Protein-1 in Gynecological Cancer
por: Sobočan, Monika, et al.
Publicado: (2020)

Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review
por: Padežnik, Tjaša, et al.
Publicado: (2023)

Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Herrero-Vicent, Carmen, et al.
Publicado: (2017)

Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancer
por: Elghazawy, Hagar, et al.
Publicado: (2021)

Prognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer
por: Čeprnja, Toni, et al.
Publicado: (2022)

Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer
por: Kilmartin, Darren, et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
por: García-Teijido, Paula, et al.
Publicado: (2016)

Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas
por: Hidalgo, Jose Villacorta, et al.
Publicado: (2014)

Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
por: Tian, Tian, et al.
Publicado: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
por: Gomez-Macias, Gabriela Sofia, et al.
Publicado: (2020)

Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer
por: Huertas-Caro, Carlos Alexander, et al.
Publicado: (2022)

Towards an immunoscore for triple negative breast cancer (TNBC): lymphocytic infiltrate predicts outcome
por: Adams, Sylvia, et al.
Publicado: (2013)

Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
por: Yuan, Yinyin
Publicado: (2015)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
por: Jamiyan, Tsengelmaa, et al.
Publicado: (2020)

Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy
por: Sikandar, Bushra, et al.
Publicado: (2017)

Multigene Expression Signatures in Early Hormone Receptor Positive HER 2 Negative Breast Cancer
por: Ovcaricek, Tanja, et al.
Publicado: (2019)

Gynaecological cancers and their cell lines
por: Skok, Kristijan, et al.
Publicado: (2021)

Initiation and elongation factor co-expression correlates with recurrence and survival in epithelial ovarian cancer
por: Sobočan, Monika, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes and CD8(+) T cells predict survival of triple-negative breast cancer
por: Vihervuori, H., et al.
Publicado: (2019)

Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
por: Kuroda, Hajime, et al.
Publicado: (2021)

Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
por: Loi, Sherene, et al.
Publicado: (2022)

Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients
por: Dovnik, Nina Fokter, et al.
Publicado: (2016)

Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
por: Lee, Miseon, et al.
Publicado: (2019)

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
por: Kuroda, H., et al.
Publicado: (2021)

LAG-3(+) tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
por: Hu, Guoming, et al.
Publicado: (2023)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
por: Su, Guan-Hua, et al.
Publicado: (2022)

The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
por: Li, Ruonan, et al.
Publicado: (2023)

Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer
por: Huertas-Caro, Carlos A., et al.
Publicado: (2023)

The presence of PD-1 positive tumor infiltrating lymphocytes in triple negative breast cancers is associated with a favorable outcome of disease
por: Brockhoff, Gero, et al.
Publicado: (2017)

Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer
por: Zahran, Asmaa M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap5co6j9h6rlaeqd4adise2l5k